Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$54.2 - $69.69 $1,029 - $1,324
19 Added 0.24%
7,946 $549,000
Q4 2023

Feb 13, 2024

SELL
$48.72 - $65.43 $5,554 - $7,459
-114 Reduced 1.42%
7,927 $437,000
Q3 2023

Nov 13, 2023

BUY
$50.28 - $64.61 $53,246 - $68,421
1,059 Added 15.17%
8,041 $466,000
Q2 2023

Aug 04, 2023

BUY
$37.29 - $53.83 $2,125 - $3,068
57 Added 0.82%
6,982 $375,000
Q1 2023

May 12, 2023

BUY
$37.61 - $45.72 $1,316 - $1,600
35 Added 0.51%
6,925 $275,000
Q4 2022

Feb 10, 2023

BUY
$31.9 - $41.95 $797 - $1,048
25 Added 0.36%
6,890 $277,000
Q3 2022

Nov 14, 2022

SELL
$29.83 - $38.01 $29 - $38
-1 Reduced 0.01%
6,865 $221,000
Q2 2022

Aug 12, 2022

BUY
$23.09 - $33.46 $10,644 - $15,425
461 Added 7.2%
6,866 $204,000
Q1 2022

May 13, 2022

SELL
$26.91 - $47.15 $6,431 - $11,268
-239 Reduced 3.6%
6,405 $180,000
Q4 2021

Feb 11, 2022

BUY
$32.97 - $56.85 $16,946 - $29,220
514 Added 8.38%
6,644 $306,000
Q3 2021

Nov 12, 2021

SELL
$26.48 - $35.99 $6,196 - $8,421
-234 Reduced 3.68%
6,130 $201,000
Q2 2021

Aug 13, 2021

BUY
$31.86 - $38.6 $2,548 - $3,088
80 Added 1.27%
6,364 $223,000
Q1 2021

May 07, 2021

SELL
$28.4 - $36.14 $2,101 - $2,674
-74 Reduced 1.16%
6,284 $227,000
Q4 2020

Feb 12, 2021

SELL
$23.69 - $31.47 $3,671 - $4,877
-155 Reduced 2.38%
6,358 $185,000
Q3 2020

Nov 04, 2020

SELL
$26.38 - $33.1 $3,957 - $4,965
-150 Reduced 2.25%
6,513 $184,000
Q2 2020

Aug 12, 2020

BUY
$29.93 - $50.1 $10,804 - $18,086
361 Added 5.73%
6,663 $215,000
Q1 2020

May 04, 2020

SELL
$30.35 - $67.14 $9,469 - $20,947
-312 Reduced 4.72%
6,302 $257,000
Q4 2019

Feb 05, 2020

SELL
$55.65 - $79.83 $9,961 - $14,289
-179 Reduced 2.64%
6,614 $408,000
Q3 2019

Nov 08, 2019

BUY
$64.7 - $85.39 $1,358 - $1,793
21 Added 0.31%
6,793 $495,000
Q2 2019

Aug 13, 2019

BUY
$67.77 - $82.2 $47,439 - $57,540
700 Added 11.53%
6,772 $557,000
Q1 2019

May 06, 2019

SELL
$45.83 - $70.54 $7,470 - $11,498
-163 Reduced 2.61%
6,072 $428,000
Q4 2018

Feb 13, 2019

SELL
$41.17 - $56.44 $2,964 - $4,063
-72 Reduced 1.14%
6,235 $281,000
Q3 2018

Nov 09, 2018

BUY
$52.95 - $71.34 $1,270 - $1,712
24 Added 0.38%
6,307 $357,000
Q2 2018

Aug 08, 2018

BUY
$56.38 - $68.08 $65,062 - $78,564
1,154 Added 22.5%
6,283 $420,000
Q1 2018

May 07, 2018

SELL
$56.98 - $72.41 $77,663 - $98,694
-1,363 Reduced 21.0%
5,129 $299,000
Q4 2017

Feb 09, 2018

BUY
$53.3 - $74.56 $1,332 - $1,864
25 Added 0.39%
6,492 $418,000
Q3 2017

Nov 09, 2017

BUY
$43.46 - $52.49 $281,055 - $339,452
6,467
6,467 $339,000

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $982M
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.